NRGene (TASE: NRGN), a leading genomics AI company and Kayagene, a pioneer in hemp and Cannabis breeding, are pleased to announce the completion of a milestone in their strategic research collaboration.
Due to the illicit history of Cannabis, the market is experiencing lack of diversity amongst seed genetics circulating the industry.
When breeding new varieties of any crop, traditional methods are slow to produce results, taking on average five to six years for a single new variety to be commercialized.
Utilizing modern, non-GMO, genomic tools, we can cut the Cannabis breeding process in half.
Evolution in breeding technologies will aid in creating appeal and versatility.
From Kayagene’s inception, the company has invested heavily in genomic tools.
We were the first to have not only one, but three high quality fully phased Cannabis genomes. These are critical in setting the foundation for our suite of genomic tools.
Quickly seeing the value for growers to utilize day-neutral or “autoflower” genetics, we set out to identify molecular markers for this trait. By placing an emphasis on breeding autoflower varieties, Kayagene will accelerate Cannabis into the future.
The future of Cannabis breeding is dependent upon capturing the remaining diversity in the crop and being good stewards of that resource.
Kayagene is advancing the Cannabis industry through the development of highly competitive, vigorous and reliable Cannabis genetics.
We’re collaborating with breeders, seed companies and processors to create custom varieties suitable for unique audiences and essential market needs.